<  HOME  <  NEWS  <  2006 PRESS RELEASES
2006 PRESS RELEASES
Receive E-mail Alerts
|
RSS Feeds
Keyword Search
 
2006 | 2005 | 2004 | 2003 | 2002
DateTitle 
12/15/06Icagen Announces Presentations Related to Senicapoc at the 2006 Annual Meeting of the American Society of HematologyPrinter Friendly Version
11/13/06Icagen Reports Third Quarter 2006 Financial ResultsPrinter Friendly Version
11/06/06Icagen Announces Third Quarter Conference CallPrinter Friendly Version
11/03/06Icagen to Present at Two Upcoming Investor ConferencesPrinter Friendly Version
10/31/06Icagen Reports Presentations at Annual Society for Neuroscience MeetingPrinter Friendly Version
10/30/06Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing RequirementsPrinter Friendly Version
09/21/06Icagen to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/12/06Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043Printer Friendly Version
08/10/06Icagen Reports Second Quarter 2006 Financial ResultsPrinter Friendly Version
08/07/06Icagen Announces the Appointment of Adeoye Y. Olukotun, M.D., MPH, FACC to the Company's Board of DirectorsPrinter Friendly Version
08/04/06Icagen Reports Results of the Interim Analysis in Phase III Clinical Trial of ICA-17043Printer Friendly Version
07/27/06Icagen Announces Second Quarter Conference CallPrinter Friendly Version
06/21/06Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043Printer Friendly Version
06/08/06Icagen to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/31/06Icagen Initiates Pediatric Clinical Development of ICA-17043 for Sickle Cell DiseasePrinter Friendly Version
05/25/06Icagen Names Senior Vice President Clinical and Regulatory AffairsPrinter Friendly Version
05/09/06Icagen Reports First Quarter 2006 Financial ResultsPrinter Friendly Version
04/25/06Icagen Announces First Quarter Conference CallPrinter Friendly Version
04/21/06Icagen to Present at the UBS Global Specialty Pharmaceuticals ConferencePrinter Friendly Version
04/03/06Icagen to Present at The CIBC Annual Biotechnology & Specialty Pharmaceuticals ConferencePrinter Friendly Version
03/28/06Icagen to Webcast Upcoming Sickle Cell Disease Day Investor and Analyst MeetingPrinter Friendly Version
03/06/06Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043Printer Friendly Version
03/03/06Icagen Announces Planned Retirement of Heyward Hull, Pharm.D., Senior Vice President, Clinical Development and Regulatory AffairsPrinter Friendly Version
03/01/06Icagen Reports Fourth Quarter and Full Year 2005 Financial ResultsPrinter Friendly Version
02/22/06Icagen Announces Fourth Quarter and Full Year 2005 Results Conference CallPrinter Friendly Version
02/15/06Icagen Reports Fourth Quarter And Full Year 2004 Financial Results And Reports Results Of Phase lb Clinical Trial Of ICA-69673Printer Friendly Version
02/08/06 ICAGEN TO PRESENT AT THE BIO CEO & INVESTOR CONFERENCEPrinter Friendly Version
02/03/06 ICAGEN TO PRESENT AT THE 24th ANNUAL JPMORGAN HEALTHCARE CONFERENCEPrinter Friendly Version
01/30/06 ICAGEN'S PHASE III CLINICAL TRIAL OF ICA-17043 ON COURSEPrinter Friendly Version

Recent News
09/03/10
Icagen Sets Date for Reverse Stock Split
+ more
Upcoming Events
Icagen Inc at Rodman & Renshaw Global Investment Conference
Stifel Nicolaus Annual Healthcare Conference
+ more




 Contact Us     Directions      Site MapCopyright © 2005 Icagen, Inc.   All rights reserved